NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 225 filers reported holding NOVAVAX INC in Q1 2023. The put-call ratio across all filers is 1.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,046 | -39.2% | 3,045 | -41.2% | 0.00% | 0.0% |
| Q2 2023 | $36,260 | +158.4% | 5,180 | +142.5% | 0.00% | 0.0% |
| Q1 2023 | $14,035 | +26890.4% | 2,136 | -69.5% | 0.00% | 0.0% |
| Q4 2022 | $52 | -99.7% | 6,994 | +328.3% | 0.00% | 0.0% |
| Q3 2022 | $20,000 | +122.2% | 1,633 | +435.4% | 0.00% | – |
| Q2 2022 | $9,000 | -25.0% | 305 | -40.3% | 0.00% | – |
| Q1 2022 | $12,000 | -55.6% | 511 | +163.4% | 0.00% | -100.0% |
| Q4 2021 | $27,000 | -48.1% | 194 | -21.1% | 0.00% | 0.0% |
| Q3 2021 | $52,000 | -24.6% | 246 | -23.1% | 0.00% | 0.0% |
| Q2 2021 | $69,000 | +27.8% | 320 | +9.6% | 0.00% | 0.0% |
| Q1 2021 | $54,000 | +50.0% | 292 | -13.1% | 0.00% | 0.0% |
| Q4 2020 | $36,000 | +38.5% | 336 | +39.4% | 0.00% | -50.0% |
| Q3 2020 | $26,000 | – | 241 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | -100.0% | 0.00% | – |
| Q1 2020 | $0 | – | 13 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 66,810 | $13,850,000 | 10.84% |
| Parametrica Management Ltd | 60,296 | $12,484,000 | 9.33% |
| RA Capital Management | 2,097,794 | $434,894,000 | 6.03% |
| Foresite Capital Management II, LLC | 67,373 | $13,967,000 | 4.96% |
| Samsara BioCapital, LLC | 82,600 | $17,124,000 | 2.69% |
| Rock Springs Capital Management LP | 455,000 | $94,326,000 | 1.98% |
| Tri Locum Partners LP | 19,300 | $4,001,000 | 1.59% |
| SECTORAL ASSET MANAGEMENT INC | 89,450 | $18,544,000 | 1.54% |
| Foresite Capital Management III, LLC | 5,000 | $1,037,000 | 1.44% |
| TSP Capital Management Group, LLC | 18,525 | $3,840,000 | 1.31% |